Coherus Oncology, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Viret Jean-Frederic | Chief Financial Officer | Option Exercise | 3,159 | $10.05 | $31,748 | 11,672 | Sep 18, 2019 |
| Anicetti Vincent R | Chief Operating Officer | Sale | 2,500 | $20.03 | $50,075 | 19,310 | Sep 16, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 6,058 | $21.75 | $131,762 | 8,513 | Aug 21, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 3,000 | $19.04 | $57,120 | 8,513 | Aug 19, 2019 |
| Anicetti Vincent R | Chief Operating Officer | Sale | 2,500 | $19.00 | $47,500 | 19,310 | Aug 14, 2019 |
| Anicetti Vincent R | Chief Operating Officer | Sale | 2,500 | $19.20 | $48,000 | 19,310 | Jul 15, 2019 |
| HEALY JAMES | — | Sale | 160,000 | $22.61 | $3,617,600 | 1,933,221 | Jun 28, 2019 |
| HEALY JAMES | — | Sale | 317,130 | $21.37 | $6,777,068 | 2,293,221 | Jun 20, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 3,000 | $19.31 | $57,930 | 12,180 | Jun 19, 2019 |
| Wahlstrom Mats | — | Other | 178,528 | — | — | — | May 31, 2019 |
| Lanfear Dennis M | President & CEO | Sale | 32,398 | $19.49 | $631,437 | 1,284,184 | May 30, 2019 |
| HEALY JAMES | — | Sale | 257,870 | $20.69 | $5,335,330 | 2,610,351 | May 22, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 3,000 | $14.92 | $44,760 | 13,185 | Mar 20, 2019 |
| Lanfear Dennis M | President and CEO | Award / Grant | 50,265 | — | — | 142,884 | Jan 11, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Tax Withholding | 6,297 | $12.37 | $77,894 | 16,185 | Jan 11, 2019 |
| Anicetti Vincent R | Chief Operating Officer | Tax Withholding | 6,404 | $12.37 | $79,217 | 17,295 | Jan 11, 2019 |
| Vexler Vladimir | Chief Scientific Officer | Award / Grant | 15,562 | — | — | 23,390 | Jan 11, 2019 |
| Viret Jean-Frederic | Chief Financial Officer | Option Exercise | 740 | $13.50 | $9,990 | 4,519 | Sep 21, 2018 |
| FINCK BARBARA K | Chief Medical Officer | Sale | 1,760 | $18.58 | $32,701 | 37,043 | Sep 10, 2018 |
| HEALY JAMES | — | Sale | 25,000 | $20.50 | $512,500 | 2,868,221 | Aug 29, 2018 |
| FINCK BARBARA K | Chief Medical Officer | Option Exercise | 1,760 | $1.42 | $2,499 | 38,803 | Aug 13, 2018 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 9,291 | $18.56 | $172,441 | 3,779 | Jul 23, 2018 |
| FINCK BARBARA K | Chief Medical Officer | Sale | 500 | $15.03 | $7,515 | 37,043 | Jul 10, 2018 |
| FINCK BARBARA K | Chief Medical Officer | Sale | 1,760 | $15.00 | $26,400 | 37,043 | Jun 18, 2018 |
| Lanfear Dennis M | See Remarks | Sale | 20,984 | $16.26 | $341,200 | 1,316,582 | May 16, 2018 |
| Viret Jean-Frederic | Chief Financial Officer | Award / Grant | 6,966 | — | — | 9,958 | Dec 15, 2017 |
| Lanfear Dennis M | See Remarks | Award / Grant | 20,984 | — | — | 92,619 | Dec 15, 2017 |
| Watler Peter K. | Chief Technical Officer | Award / Grant | 5,900 | — | — | 5,900 | Dec 15, 2017 |
| FINCK BARBARA K | Chief Medical Officer | Award / Grant | 7,545 | — | — | 34,336 | Dec 15, 2017 |
| Herman Alan C. | Chief Scientific Officer | Award / Grant | 809 | — | — | 50,460 | Dec 15, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 17,535 | $15.02 | $263,376 | 49,651 | Aug 8, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 600 | $15.00 | $9,000 | 67,186 | Jul 5, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 1,732 | $20.98 | $36,337 | 67,786 | Jun 1, 2017 |
| Wahlstrom Mats | — | Other | 109,957 | — | — | 219,914 | May 9, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 11,333 | $20.00 | $226,660 | 79,119 | May 1, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 11,333 | $20.73 | $234,933 | 90,452 | Apr 3, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 11,333 | $24.19 | $274,145 | 101,785 | Mar 1, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 11,333 | $27.37 | $310,184 | 113,118 | Feb 1, 2017 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 3,900 | $27.00 | $105,300 | 2,992 | Jan 25, 2017 |
| Herman Alan C. | Chief Scientific Officer | Sale | 683 | $28.60 | $19,534 | 124,451 | Jan 3, 2017 |
| Viret Jean-Frederic | Chief Financial Officer | Option Exercise | 667 | $13.50 | $9,005 | 2,992 | Dec 16, 2016 |
| Wahlstrom Mats | — | Sale | 7,393 | $27.50 | $203,308 | 46,190 | Dec 8, 2016 |
| Herman Alan C. | Chief Scientific Officer | Sale | 8,133 | $27.55 | $224,064 | 135,784 | Dec 1, 2016 |
| Viret Jean-Frederic | Chief Financial Officer | Option Exercise | 3,900 | $13.50 | $52,650 | 6,225 | Nov 18, 2016 |
| Herman Alan C. | Chief Scientific Officer | Sale | 11,333 | $27.53 | $311,997 | 147,117 | Nov 1, 2016 |
| Viret Jean-Frederic | Chief Financial Officer | Sale | 3,900 | $30.62 | $119,418 | 2,325 | Oct 21, 2016 |
| Herman Alan C. | Chief Scientific Officer | Sale | 3,237 | $26.26 | $85,004 | 158,450 | Oct 3, 2016 |
| Viret Jean-Frederic | Chief Financial Officer | Option Exercise | 3,900 | $13.50 | $52,650 | 6,225 | Sep 26, 2016 |
| Lanfear Dennis M | President and CEO | Sale | 4,010 | $31.75 | $127,318 | 1,337,616 | Sep 21, 2016 |
| Lanfear Dennis M | President and CEO | Sale | 2,900 | $31.79 | $92,191 | 1,341,626 | Sep 16, 2016 |